The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease

The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease

Background: Metabolic-associated fatty liver disease (MAFLD) is an increasingly prevalent cause of chronic liver disease. In 2020, the FibroScan-AST (FAST) score was internationally validated as a new tool able to identify patients with steatohepatitis who benefit the most from further therapies, ba...

Full description

Bibliographic Details
Main Authors: Vítor Macedo Silva, Marta Freitas, Sofia Xavier, Pedro Boal Carvalho, Joana Magalhães, Carla Marinho, José Cotter
Format: Article
Language:English
Published: Karger Publishers 2022-10-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
metabolic-associated fatty liver disease
liver transient elastography
hepatology
Online Access:https://www.karger.com/Article/FullText/527027

Internet

https://www.karger.com/Article/FullText/527027

Similar Items